Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2012 1
2016 1
2017 1
2020 2
2021 4
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Grambozov B, Kalantari F, Beheshti M, Stana M, Karner J, Ruznic E, Zellinger B, Sedlmayer F, Rinnerthaler G, Zehentmayr F. Grambozov B, et al. Among authors: zellinger b. Radiother Oncol. 2023 Aug;185:109728. doi: 10.1016/j.radonc.2023.109728. Epub 2023 Jun 9. Radiother Oncol. 2023. PMID: 37301259 Free article.
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Stana M, Grambozov B, Gaisberger C, Karner J, Ruznic E, Berchtold J, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Stana M, et al. Among authors: zellinger b. Diagnostics (Basel). 2022 Apr 19;12(5):1027. doi: 10.3390/diagnostics12051027. Diagnostics (Basel). 2022. PMID: 35626183 Free PMC article.
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov B, Stana M, Kaiser B, Karner J, Gerum S, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: zellinger b. Cancers (Basel). 2022 Jan 23;14(3):573. doi: 10.3390/cancers14030573. Cancers (Basel). 2022. PMID: 35158841 Free PMC article. Review.
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature.
Kraus TFJ, Schwartz C, Machegger L, Zellinger B, Hölzl D, Schlicker HU, Pöppe J, Ladisich B, Spendel M, Kral M, Sotlar K. Kraus TFJ, et al. Among authors: zellinger b. Brain Tumor Pathol. 2022 Apr;39(2):111-119. doi: 10.1007/s10014-021-00423-0. Epub 2022 Jan 11. Brain Tumor Pathol. 2022. PMID: 35018523 Free PMC article. Review.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Grambozov B, Ruznic E, Stana M, Karner J, Fastner G, Sotlar K, Sedlmayer F, Zehentmayr F. Zellinger B, et al. Breast Cancer. 2022 Mar;29(2):274-286. doi: 10.1007/s12282-021-01308-y. Epub 2021 Dec 5. Breast Cancer. 2022. PMID: 34865205 Free PMC article.
17 results